Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00806182 · ClinicalTrials.gov registry record
Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome
A clinical trial of Opsoclonus-myoclonus Syndrome, sponsored by National Pediatric Neuroinflammation Organization.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT00806182: Completed study of Opsoclonus-myoclonus Syndrome, sponsored by National Pediatric Neuroinflammation Organization.
NCT00806182 is a study of Opsoclonus-myoclonus Syndrome that has completed, run by National Pediatric Neuroinflammation Organization. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00806182, a study of Opsoclonus-myoclonus Syndrome, has completed, sponsored by National Pediatric Neuroinflammation Organization.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and could serve as biomarkers or therapeutic targets in children with opsoclonus-myoclonus syndrome (OMS), an autoimmune complication of the tumor neuroblastoma.
Primary Outcome
Reduction in the concentration of inflammatory chemokines/cytokines between clinical time points
Conditions Studied
Study Locations (1)
Illinois
- National Pediatric Myoclonus Center, Formerly at Dept. of Neurology, Southern Illinois University School of Medicine - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2008-01 |
| Est. Completion | 2016-12 |
What the finished NCT00806182 record still lists
NCT00806182 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Opsoclonus-myoclonus Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00806182 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00806182 about?
NCT00806182 is a clinical study titled "Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome". The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and could serve as biomarkers or therapeutic targets in children with opsoclonus-myoclonus syndrome (OMS), an autoimmune complication of the tumor...
What is the current status of trial NCT00806182?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2008-01. Estimated completion is 2016-12.
What conditions does trial NCT00806182 study?
This clinical trial studies the following conditions: Opsoclonus-myoclonus Syndrome.
Who is sponsoring clinical trial NCT00806182?
This trial is sponsored by National Pediatric Neuroinflammation Organization, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00806182 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia